Latest News by Industry
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Tuesday reported a loss of $15.5 million in its second quarter.
On a per-share basis, the San Francisco-based company said it had a loss of 16 cents.
The biotech drug developer posted revenue of $50.6 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN